Skip to main content
SpringerLink
Log in

Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background:This retrospective study was designed to provide a preliminary outcome analysis in patients with positive sentinel nodes who declined axillary dissection.

Methods:A review was conducted of patients who underwent lumpectomy and sentinel lymph node excision for invasive disease between January 1998 and July 2000. Those who were found to have sentinel lymph node metastasis without completion axillary dissection were selected for evaluation. Follow-up included physical examination and mammography.

Results:Thirty-one patients were identified who met inclusion criteria. Primary invasive cell types included infiltrating ductal carcinoma, infiltrating lobular carcinoma, and mixed cellularity. Most primary tumors were T1. Nodal metastases were identified by hematoxylin and eosin stain and immunohistochemistry. Twenty-seven of the metastases were microscopic (<2 mm), and the remaining four were macroscopic. All patients received adjuvant systemic therapy. With a mean follow-up of 30 months, there have been no patients with axillary recurrence on physical examination or mammographic evaluation.

Conclusions:We have presented patients with sentinel lymph nodes involved by cancer who did not undergo further axillary resection and remain free of disease at least 1 year later. This preliminary analysis supports the inclusion of patients with subclinical axillary disease in trials that randomize to observation alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992; 66: 136–8.

    CAS  PubMed  Google Scholar 

  2. Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000; 64: 275–86.

    CAS  PubMed  Google Scholar 

  3. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998; 339: 941–6.

    Article  CAS  PubMed  Google Scholar 

  4. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Sentinel lymph node biopsy for staging breast cancer. Am J Surg 1998; 176: 532–7.

    CAS  PubMed  Google Scholar 

  5. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345–50.

    CAS  PubMed  Google Scholar 

  6. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg 2002; 89: 21–34.

    CAS  PubMed  Google Scholar 

  7. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999; 177: 184–7;discussion 188.

    CAS  PubMed  Google Scholar 

  8. Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999; 17: 143–9.

    CAS  PubMed  Google Scholar 

  9. Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 2001; 136: 563–8.

    CAS  PubMed  Google Scholar 

  10. Voogd AC, Coebergh JW, Repelaer van Driel OJ, et al. The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis. Breast Cancer Res Treat 2000; 62: 63–9.

    CAS  PubMed  Google Scholar 

  11. Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001; 182: 316–20.

    CAS  PubMed  Google Scholar 

  12. Ganaraj A, Kuhn JA, Jones RC, et al. Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node. Baylor University Medical Center Proceedings 2003; 16: 3–6.

    PubMed  Google Scholar 

  13. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536–41.

    CAS  PubMed  Google Scholar 

  14. Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001; 136: 688–92.

    CAS  PubMed  Google Scholar 

  15. Furukawa T, Kubota T, Tanino H, et al. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay. Anticancer Res 2000; 20: 3657–8.

    CAS  PubMed  Google Scholar 

  16. Lenert JT, Vlastos G, Mirza NQ, et al. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol 1999; 6: 762–7.

    CAS  PubMed  Google Scholar 

  17. Rouzier R, Extra JM, Klijanienko J, et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 2002; 20: 1304–10.

    PubMed  Google Scholar 

  18. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997; 15: 2483–93.

    CAS  PubMed  Google Scholar 

  19. Baxter N, McCready D, Chapman JA, et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol 1996; 3: 235–40.

    CAS  PubMed  Google Scholar 

  20. Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 1989; 320: 473–8.

    Article  CAS  PubMed  Google Scholar 

  21. Singletary SE. Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why? J Am Coll Surg 2001; 192: 220–30.

    CAS  PubMed  Google Scholar 

  22. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999; 84: 138–42.

    CAS  PubMed  Google Scholar 

  23. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674–81.

    Article  CAS  PubMed  Google Scholar 

  24. Cancer research campaign (King’s/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party. Lancet 1980; 2: 55–60.

    Google Scholar 

  25. Lythgoe JP, Palmer MK. Manchester regional breast study—5 and 10 year results. Br J Surg 1982; 69: 693–6.

    CAS  PubMed  Google Scholar 

  26. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast. Br J Surg 1980; 67: 170–4.

    CAS  PubMed  Google Scholar 

  27. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet 1992; 339: 1245–8.

    CAS  PubMed  Google Scholar 

  28. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival—a Bayesian meta-analysis. Ann Surg Oncol 1999; 6: 109–16.

    CAS  PubMed  Google Scholar 

  29. Bland KI, Scott-Conner CE, Menck H, Winchester DP. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 1999; 188: 586–95;discussion 595–6.

    CAS  PubMed  Google Scholar 

  30. Hayward J, Caleffi M. The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award. Arch Surg 1987; 122: 1244–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Baylor University Medical Center, Dallas, Texas

    Jerri S. Fant MD, Michael D. Grant MD, Sally M. Knox MD, Sheryl A. Livingston MSN, RN, Kimberly Ridl MD, Ronald C. Jones MD & Joseph A. Kuhn MD

  2. 3409 Worth Street, Suite 420, Dallas, TX 75246

    Joseph A. Kuhn MD

Authors
  1. Jerri S. Fant MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael D. Grant MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sally M. Knox MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sheryl A. Livingston MSN, RN
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kimberly Ridl MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ronald C. Jones MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joseph A. Kuhn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph A. Kuhn MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fant, J.S., Grant, M.D., Knox, S.M. et al. Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection. Ann Surg Oncol 10, 126–130 (2003). https://doi.org/10.1245/ASO.2003.04.022

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.04.022

Key Words:

Search

Navigation